Programming Schedule | American Diabetes Association

Scientific Sessions Registration Open BannerScientific Sessions Programming Schedule

The program schedule is current as of 2/10/2023 and updates will continue to be made. All sessions will take place in U.S. Pacific Time

10:30 a.m.-11:30 a.m.

  • Welcome to the 83rd Scientific Sessions!

11:30 a.m.-12:30 p.m

  • (Symposium) "Pathway to Stop Diabetes" Symposium 

12:45 p.m.-1:45 p.m.

  • (Debate) To Eat or Not to Eat? Fasted vs. Postprandial Exercise for Glycemic Management (Includes Livestream)    
  • (Debate) Are Two Better than One? Initial Combination Therapy in Type 2 Diabetes Mellitus (Includes Livestream)
  • (Symposium) Overcoming Therapeutic Inertia—Leveraging the Diabetes Care Interprofessional Team (Includes Livestream) 
  • (Debate) Where Lie the Keys to Type 2 Diabetes Prevention? Population Health or Personalized Medicine? (Includes Livestream)
  • (Oral Presentations) Hypoglycemia
  • (Oral Presentations) Lipids
  • (Oral Presentations) Diabetic Kidney Disease
  • (Oral Presentations) Clinical Therapeutics
  • (Oral Presentations) Youth
  • (Oral Presentations) Immunology
  • (Oral Presentations) Insulin Action/Molecular Metabolism
  • (Oral Presentations) Integrated Physiology/Obesity
  • (Oral Presentations) Islet Biology/Insulin Secretion

2:00 p.m.-3:30 p.m.

  • (Ask the Expert) Management of the Athlete with Diabetes (Includes Livestream)
  • (Oral Presentations) Macrovascular Complications (With Edwin Bierman Award Lecture) (Includes Livestream)
  • (Oral Presentations) Psychosocial/Behavioral Medicine (With Richard R. Rubin Award Lecture) (Includes Livestream)
  • (Oral Presentations) Pregnancy
  • (Oral Presentations) Clinical Therapeutics
  • (Oral Presentations) New Technology
  • (Oral Presentations) Epidemiology
  • (Oral Presentations) Genetics
  • (Oral Presentations) Beta-Cell Replacement
  • (Oral Presentations) Insulin Action/Molecular Metabolism
  • (Oral Presentations) Obesity/Pathogenesis of Obesity
  • (Oral Presentations) Islet Biology/Insulin Secretion (Includes Livestream)

3:45 p.m.-5:15 p.m.

  • (Symposium) Real-World Hypoglycemia in Older Adults with Diabetes (Includes Livestream)
  • (Symposium) Efficacy, Engagement, and Sustainability of Dietary Management Options in Type 2 Diabetes—Time for a Reappraisal?
  • (Symposium) Translating Psychosocial Care into Real-World Practice Settings
  • (Ask the Expert) Interactive Case Studies—AID Systems—Which Setting Would You Change? (Includes Livestream)
  • (Panel Discussion) Remission or Bust!
  • (Symposium) Genetics of Glucose Metabolism in Pregnancy
  • (Symposium) Glucagon Fest
  • (Symposium) Immigration and Diabetes—Diabetes Risk, Prevention, and Management in a Changing American Landscape (Includes Livestream)
  • (Symposium) The Quest to Delay or Prevent Type 1 Diabetes Onset—Recent Interventional Trials (Includes Livestream)
  • (Symposium) Designer Beta Cells
  • (Panel Discussion) Interoception—Conversations with Adipocytes
  • (Symposium) Welcome to Exosomes—Their Role in Obesity
  • (Symposium) Diabetic Myopathy and Muscle Metabolism

5:30 p.m.-6:30 p.m.

  • (Debate) Should We Curb the Carbs? (Includes Livestream)
  • (Debate) Do-It-Yourself (DIY) Devices vs. Commercial Closed-Loop Systems for Managing Type 1 Diabetes (Includes Livestream)
  • (Debate) Hope or Hype—Role of Microbiome in Obesity (Includes Livestream)
  • (Oral Presentations) Foot Care/Lower Extremities
  • (Oral Presentations) Neuropathy
  • (Oral Presentations) Retinopathy (Includes Livestream)
  • (Oral Presentations) Clinical Nutrition
  • (Oral Presentations) Education
  • (Oral Presentations) Exercise
  • (Oral Presentations) Clinical Therapeutics
  • (Oral Presentations) Youth
  • (Oral Presentations) Genetics
  • (Oral Presentations) Metabolism, In Vivo (Humans)

6:30 p.m.-8:30 p.m

  • ADA Networking Reception

8:00 a.m.-9:30 a.m.

  • (Symposium) The Goldilocks Paradigm of Physical Activity and the Foot in Persons with Diabetes (Includes Livestream)
  • (Symposium) Implementation of Guideline-Directed Medical Therapy for Cardiometabolic Disease—Emerging Multidisciplinary Initiatives
  • (Panel Discussion) Behavioral Markers of Diabetes Self-Management—State of the Science and Measurement Controversies—Honoring the Legacy of Mark Peyrot
  • (Symposium) The Heart of the Matter—Cardiovascular Health during Pregnancy and Beyond
  • (Symposium) Overcoming Obstacles in Diabetes Management
  • (Symposium) Continuous Glucose Monitoring in Type 2 Diabetes—Are We There Yet? (Includes Livestream)
  • (Symposium) Diabetes in the Child with Obesity
  • (Symposium) ADA Diabetes Care Symposium—Social Determinants of Health—Impact on Diabetes Development and Care
  • (Symposium) The Road Less Traveled—U.S. Rurality and Diabetes
  • (Symposium) Type 1 Diabetes through Another Lens—Lessons from Other Disease Settings (Includes Livestream)
  • (Symposium) Mitochondrial Metabolism and Glucose Homeostasis
  • (Symposium) Beyond “Calories In, Calories Out” in Treating Obesity (Includes Livestream)
  • (Symposium) Endoplasmic Reticulum (ER)—Stressed-Out Beta Cells

9:45 a.m.-11:15 a.m.

  • ADA CEO Address; President, Health Care & Education Address; and Outstanding Educator in Diabetes Award Lecture (Includes Livestream) 

11:30 a.m.-12:30 p.m.

  • (Professional Interest Group Discussion) Foot Care (Includes Livestream)        
  • (Professional Interest Group Discussion) Exercise Physiology—Lactate Reimagined—More than Just a Waste Product
  • (Professional Interest Group Discussion) Nutritional Sciences and Metabolism—Novel Methods of Dietary Assessment
  • (Professional Interest Group Discussion) Women’s Interprofessional Network of the ADA (WIN ADA)—Amplifying Women's Voices in the Diabetes Workforce—A Panel Discussion (Includes Livestream)
  • (Professional Interest Group Discussion) Pregnancy and Reproductive Health—Metformin Use in Type 2 Diabetes during Pregnancy—A Debate (Includes Livestream)
  • (Professional Interest Group Discussion) Clinical Centers and Programs
  • (Professional Interest Group Discussion) Islet Biology Development and Function—Alpha, Beta, and Delta Cells of the Islets—More than Just Neighbors (Includes Livestream)
  • (Professional Development) Learn How to Pitch Your Entrepreneurial Idea and Get Funding
  • General Poster Session
  • ePoster Theater Sessions

1:30 p.m.-3:00 p.m.

  • (Ask the Expert) Interactive Case Studies—Optimizing Diabetes Technology in Special Populations (Includes Livestream)
  • (Oral Presentations) Hypoglycemia
  • (Oral Presentations) Foot Care/Lower Extremities (With Roger Pecoraro Award Lecture) (Includes Livestream)
  • (Oral Presentations) Macrovascular Complications
  • (Oral Presentations) Psychosocial/Behavioral Medicine
  • (Oral Presentations) Health Care Improvement
  • (Oral Presentations) Pregnancy
  • (Oral Presentations) Clinical Therapeutics
  • (Oral Presentations) Epidemiology
  • (Oral Presentations) Immunology (Includes Livestream)
  • (Oral Presentations) Insulin Action/Molecular Metabolism
  • (Oral Presentations) Metabolism, In Vivo (Animals)
  • (Oral Presentations) Islet Biology/Insulin Secretion (Includes Livesteam)

3:15 p.m.-4:15 p.m.

  • Kelly West Award for Outstanding Achievement in Epidemiology Lecture (Includes Livestream)
  • (Panel Discussion) The Future Is Now—Artificial Intelligence and Diabetes Foot Disease
  • (Panel Discussion) Hypoglycemia as a Quality Measure—Rationale, Challenges, and Opportunities
  • (Panel Discussion) Above and Beyond the Regular Lipid Panel—Are Additional Measurements Really Needed?
  • (Symposium) The Evolving Clinical Spectrum of Diabetic Neuropathy
  • (Debate) Nutrition in Pregnancy—Is Low-Carb a No-Go?
  • (Debate) Technology or Immunomodulation—The Best Course for Management of Type 1 Diabetes
  • (Panel Discussion) What Can Diabetes Quality Teams Learn from Engineers and Designers?
  • (Panel Discussion) Diabetes Endotypes—Defined by DNA?
  • (Panel Discussion) The New Normal—Perspectives on Treatment and Trials as Immunotherapies Enter the Type 1 Diabetes Clinical Landscape (Includes Livestream)
  • (Symposium) Twitter Bugs—Dancing between the Carbohydrate–Insulin and Energy-Balance Models (Includes Livestream)
  • (Debate) Only Time Will Tell—Early Eating or Just Eating? (Includes Livestream)
  • (Debate) Is It Time to Revise Our Thinking on the Role of the K(ATP) Channel in Insulin Secretion?

4:30 p.m.-6:00 p.m.

  • (Main Event) Innovation Challenge (Includes Livestream)
  • (Symposium) Joint ADA/AACC Symposium—Hyperglycemia in the Hospital—Are Our Tools for Measurement Accurate Enough?
  • (Symposium) Joint ADA/EASD Symposium—Precision Medicine in Diabetes (PMDI) (Includes Livestream)         
  • (Symposium) Multiancestry Genome-Wide Association Studies (GWAS) and Polygenic Risk Score (PRS)
  • (Oral Presentations) Psychosocial/Behavioral Medicine (Includes Livestream)
  • (Oral Presentations) Clinical Therapeutics
  • (Oral Presentations) New Technology
  • (Oral Presentations) Beta-Cell Replacement (Includes Livestream)
  • (Oral Presentations) Metabolism, In Vivo (Humans)
  • (Oral Presentations) Islet Biology/Insulin Secretion

8:00 a.m.-9:30 a.m.

  • (Symposium) New Treatment Possibilities for Cardiovascular Residual Risk in Diabetes? (Includes Livestream)
  • (Symposium) Diabetes Kidney Disease in Type 1 and Type 2 Diabetes—The Same Disease?
  • (Symposium) The NIDDK Diabetic Foot Consortium—So People with Diabetes May Stand Firm
  • (Symposium) Hot Topics in Nutrition—What’s the Evidence? (Includes Livestream)
  • (Panel Discussion) Do Quality Improvement Efforts Reduce Health Care Disparities?
  • (Symposium) Automated Insulin Delivery Use among Pregnant Women with Type 1 Diabetes—Past, Present, and Future
  • (Symposium) Transforming Therapy with Ultra-Long-Acting Insulins
  • (Panel Discussion) Updates in ADA’s Standards of Care in Diabetes 2023 (Includes Livestream)
  • (Symposium) Joint ADA/JDRF Symposium—Global Perspective on Population Level Type 1 Diabetes Screening and Monitoring
  • (Symposium) Real-World Data in Diabetes Research—Promise or Peril?
  • (Symposium) It’s About Time—Eating and Exercising in Metabolic Health
  • (Symposium) Nutrient-Stimulated Hormones—Anti-Obesity Pharmacotherapy Game Changers (Includes Livestream)
  • (Symposium) ADA Diabetes Journal Symposium—Staying in Network—Adipocyte Communication in Regulation of Energy Balance

9:45 a.m.-11:15 a.m.

  • President, Medicine & Science Address and Banting Medal for Scientific Achievement (Includes Livestream)

1:30 p.m.-3:00 p.m.

  • (Ask the Expert) Downloading Glucose Data Everywhere or All in One Place (Includes Livestream)
  • (Symposium) Improving Inclusive Care in Pediatric Diabetes Clinics—ADA Youth Strategies Committee Symposium
  • (Symposium) The Islet-Cell Interactome (Includes Livestream)
  • (Oral Presentations) Hypoglycemia
  • (Oral Presentations) Macrovascular Complications
  • (Oral Presentations) Health Care Improvement
  • (Oral Presentations) Clinical Therapeutics
  • (Oral Presentations) New Technology
  • (Oral Presentations) Pregnancy (With Norbert Freinkel Award Lecture) (Includes Livestream)
  • (Oral Presentations) Genetics (Includes Livestream)
  • (Oral Presentations) Immunology
  • (Oral Presentations) Insulin Action/Molecular Metabolism
  • (Oral Presentations) Obesity/Pathogenesis of Obesity
  • (Oral Presentations) Metabolism, In Vivo (Animals)

3:15 p.m.-4:15 p.m.

  • (Debate) What’s the Verdict on Telehealth for Behavioral and Psychological Diabetes Care? (Includes Livestream)
  • (Debate) Duel-Incretin Duel (Includes Livestream)
  • (Debate) Aging-Related Metabolic Disease—Major Drivers and Therapeutic Strategies (Includes Livestream)
  • (Oral Presentations) Lipids  (Includes Livestream)
  • (Oral Presentations) Diabetic Kidney Disease
  • (Oral Presentations) Neuropathy
  • (Oral Presentations) Retinopathy
  • (Oral Presentations) Clinical Nutrition
  • (Oral Presentations) Education
  • (Oral Presentations) Exercise
  • (Oral Presentations) Epidemiology
  • (Oral Presentations) Beta-Cell Replacement
  • (Oral Presentations) Insulin Action/Molecular Metabolism
  • (Oral Presentations) Metabolism, In Vivo (Animals)

4:30 p.m.-6:00 p.m.

  • (Panel Discussion) Current Controversies in the Primary Prevention of Diabetes Macrovascular Complications (Includes Livestream)
  • (Symposium) Creating a World without Visual Loss from Diabetes
  • (Panel Discussion) Let’s Talk Treatment—Discussing Options for Weight and Diabetes Management
  • (Symposium) Joint ADA/ADCES Symposium—Implementing Technology into a Busy Practice—It Takes a Village! (Includes Livestream)
  • (Panel Discussion) Time-in-Range—Where Are We Headed in 2023? (Includes Livestream)
  • (Symposium) Improving Outcomes for Adolescents with Type 2 Diabetes
  • (Symposium) Oral Semaglutide for Treatment of Obesity and Type 2 Diabetes—Results from OASIS 1 and PIONEER PLUS Trials (Includes Livestream)
  • (Symposium) The Ongoing Impact of the DCCT/EDIC Study at 40 Years
  • (Symposium) Controlling the Communicators—Cytokine-Specific Therapies to Preserve Beta-Cell Function in Type 1 Diabetes
  • (Symposium) Cellular Cross Talk Regulating Insulin Action
  • (Symposium) How Sex Shapes Metabolism and Glucose Homeostasis
  • (Symposium) Chrononutrition for the Prevention and Treatment of Diabetes
  • (Symposium) Beta-Cell Identity from Prenatal Life to Death

8:00 a.m.-9:30 a.m.

  • (Symposium) SGLT2i and GLP-1RA in Cardiovascular Disease—An Update for Clinical Practice in 2023 (Includes Livestream)
  • (Panel Discussion) Empowering the Acute Care Team to Optimize Diabetes Care and Education
  • (Symposium) Able-Bodied Aging—Physical Activity Considerations for Older Adults with Diabetes
  • (Symposium) Joint ADA/ISPAD Symposium—Why Aren't All Guidelines the Same? A Focused Review of Recommendations from ISPAD 2022 and ADA 2023
  • (Symposium) ADA Symposium—Major Advances and Discoveries in Diabetes—The Year in Review (Includes Livestream)
  • (Symposium) NIDDK Early Career Investigator Symposium—Behavioral and Physiological Adaptations to Optimize Glucose Control with Technology—What Is Needed to Improve Outcomes and to Overcome Access and Adoption Barriers?
  • (Symposium) All the Omics—What Do They Tell Us about Diabetes?
  • (Symposium) Engineering and Site Consideration for Cell Therapy
  • (Symposium) Observing Metabolism through New Lenses 
  • (Symposium) Single-Cell RNAseq Revolution—Decipher Metabolism One Cell at a Time
  • (Symposium) Metabolic Adaptation to Weight Loss in Humans
  • (Symposium) The Jekyll and Hyde of Inflammatory Signals in Islets (Includes Livestream)

9:45 a.m.-11:15 a.m.

  • National Scientific & Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture (Includes Livestream)

11:30 a.m.-12:30 p.m.

  • (Professional Development) Cultivating Provider Resiliency and Preventing Burnout (Includes Livestream)
  • (Professional Interest Group Discussion) Diabetes Technology (Includes Livestream)
  • (Professional Interest Group Discussion) Health Care Improvement—Best Practices in Implementing ADA’s Standards of Care in Diabetes (Includes Livestream)
  • (Professional Interest Group Discussion) Public Health and Epidemiology—Have We Succeeded in Type 2 Diabetes Primary Prevention? A Debate
  • (Professional Interest Group Discussion) Immunology, Immunogenetics, and Beta-Cell Replacement (Includes Livestream)
  • General Poster Session
  • ePoster Theater Sessions

1:30 p.m.-3:00 p.m.

  • (Panel Discussion) Joint ADA/ASN Symposium—How Do We Address the Psychosocial Determinants of Health in Diabetes and Kidney Disease? (Includes Livestream)
  • (Symposium) What Is the Best Approach to the Management of Painful Diabetic Neuropathy? 
  • (Symposium) Exercise as Medicine—Physical Activity for Preventing and Managing Diabetes Complications
  • (Symposium) Extending Our Reach—Using Technology and Clinical Collaborations to Improve Outcomes
  • (Symposium) Overcoming Barriers to Diabetes Technology
  • (Symposium) Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon Receptor Triagonist—Obesity, NAFLD, and T2D Phase 2 Trial Results (Includes Livestream)
  • (Symposium) Joint ADA/The Lancet Symposium—Racial and Gender Inequalities—An International Perspective
  • (Symposium) Clinical Cell Therapy for Diabetes
  • (Symposium) Exercise and Metabolic Health—Insight from Animal Studies
  • (Symposium) Let’s Talk about Sex (Differences in Islet Biology) (Includes Livestream)
  • (Symposium) COORDINATE—Diabetes Study Results Symposium (Includes Livestream)
  • (Symposium) ADA Education Recognition Program (ERP)—Impact in Pregnancy—MOMs in Control of Diabetes of South Carolina 
  • (Oral Presentations) Insulin Action/Molecular Metabolism
  • (Oral Presentations) Metabolism, In Vivo (Humans)

3:15 p.m.-4:15 p.m.

  • (Symposium) Beyond Antihyperglycemic and Antihypertensive Agents for Diabetic Kidney Disease (Includes Livestream)
  • (Symposium) Doc, Is My GLP-1 Med Making My Sight Worse? New Considerations in Management of Diabetic Retinopathy (Includes Livestream)
  • (Symposium) Early Diagnosis of Diabetes Cardiomyopathy (DbCM)—What Can Be Done?
  • (Symposium) Updates in Diabetes and Fasting
  • (Debate) Shared Decision-Making Either Isn’t Practiced or Isn’t Working
  • (Symposium) Is Metabolic Surgery or Lifestyle/Medical Management of Type 2 Diabetes Optimal for Long-Term Health? Long-Term Outcomes of the ARMMS-T2D Randomized Trial after 7–15 Years of Follow-Up (Includes Livestream)
  • (Symposium) Standardization of Person-Reported Outcomes—A Consensus Statement
  • (Symposium) Comparing Beta-Cell Replacement vs. Artificial Pancreas—Smart Insulins with a Focus on New Innovations—Untested Technologies (Includes Livestream)
  • (Oral Presentations) Islet Biology/Insulin Secretion